Join the latest clinical trial from Greater Manchester Mental Health NHS Foundation Trust and help shape the future of healthcare.
The purpose of this trial is to test the study medication To Riluzole (BHV 4157), which is being tested for OCD.
This study is for you if:
- You are aged between 18 to 65
- You have been diagnosed with Obsessive Compulsive Disorder
- You have had symptoms for at least 1 year
- You feel your current medication isn’t working
All eligible participants could receive up to £490.
This study has been reviewed by the following Ethics Committee:
Name: North West – Greater Manchester South Research Ethics Committee
Address: 3rd Floor, Barlow House 4 Minshull Street Manchester M1 3DZ
under the following number: 21/NW/0137
Get in touch for more information on how you can get involved:
Or fill in the online form: forms.office.com/Pages/ResponsePage.aspx?id